Shan Ahmed Khan, Author at TechStock²

DigitalBridge stock jumps nearly 10% on SoftBank’s $4 billion buyout offer — what investors watch next

NEW YORK, December 30, 2025, 00:11 ET — Market closed DigitalBridge Group, Inc. shares jumped 9.7% to $15.27 on Monday after SoftBank Group said it would buy the digital infrastructure investor for about $4 billion, or $16 a share in

30 December 2025

Financial Analysis·Investment News·Mergers & Acquisitions·Stock Market·Tech Industry

Coca-Cola Consolidated (COKE) stock slides nearly 4% into year-end — what traders watch next

NEW YORK, December 30, 2025, 12:08 ET — Market closed. Shares of Coca-Cola Consolidated, Inc. fell 3.7% to $154.62 at Monday’s close, extending a five-session slide. The stock traded between $150.29 and $161.20 and was little changed after hours at

30 December 2025

Beverage Industry·Company Analysis·Financial News·Stock Market·Trading Strategies

Silver tops $80, then plunges as Musk flags China export curbs and CME tightens trading rules

NEW YORK, December 30, 2025, 00:06 ET Silver prices fell sharply on Monday after surging past $80 an ounce to record territory, a swift reversal that rattled precious metals markets into the final trading days of the year. The move

30 December 2025

Commodity Prices·Elon Musk·Financial News·Silver Market

Crocs stock slides 6% today — what Wall Street is watching next for CROX

NEW YORK, December 29, 2025, 23:17 ET — Market closed. Crocs Inc shares closed down 6.2% on Monday at $85.94, giving back early gains and finishing near the day’s lows. Investing The late-December drop lands as investors reset positions into

30 December 2025

Financial News·Investing·Stock Market·Wall Street

Mereo BioPharma stock crashes 88% after Phase 3 setrusumab miss sinks brittle-bone hopes

NEW YORK, December 29, 2025, 23:16 ET — Market closed Mereo BioPharma Group plc shares closed down 87.65% at $0.29 on Monday after the company disclosed late-stage data that failed to hit a key fracture-rate endpoint for setrusumab, its lead

30 December 2025

Biotechnology·Clinical Trials·Pharma News·Stock Market

Ultragenyx stock sinks 42% after Phase 3 setrusumab miss; what RARE investors watch nextNEW YORK, December 29, 2025, 23:21 ET — Market closed

Ultragenyx Pharmaceutical Inc shares slid on Monday after the company said two late-stage studies of setrusumab for osteogenesis imperfecta missed their primary fracture-reduction goal, prompting plans for significant expense reductions. “We are surprised and disappointed by these results,” Chief Executive

30 December 2025

Biotechnology·Clinical Trials·Investment News·Market Analysis

Cemtrex (CETX) stock ends lower as FY2025 results tout operating profit but 10-K flags going-concern doubt

NEW YORK, December 29, 2025, 23:19 ET — Market closed Cemtrex, Inc. shares closed down 7.46% at $2.11 on Monday, before the company released its full-year results after the bell showing a return to operating profit. MarketScreener The timing matters

30 December 2025

Company Updates·Earnings Reports·Financial Analysis·Investor News·Stock Market

BNAI stock doubles as Brand Engagement Network lands AI pharma deal, eyes recurring fees

NEW YORK, December 29, 2025, 23:20 ET — Market closed Brand Engagement Network, Inc shares more than doubled on Monday after the company disclosed a project agreement to develop a custom AI engagement tool tied to an established prescription drug

30 December 2025

Artificial Intelligence·Business News·Investment·Pharmaceuticals·Stocks

DRDGOLD stock sinks as gold pulls back — what moved DRD today

NEW YORK, December 29, 2025, 15:07 ET — Regular session U.S.-listed shares of South Africa’s DRDGOLD Limited were down about 8.3% at $30.55 in afternoon trading on Monday, as gold-linked equities sold off. The stock opened at $31.37 and has

29 December 2025

Financial News·Gold Prices·Investing·Stock Market

Nvidia dips on Intel stake filing as AI stocks cool; DigitalBridge jumps on SoftBank deal

NEW YORK, December 29, 2025, 15:00 ET — Regular session Nvidia shares slid on Monday after Intel disclosed in a filing that the AI-chip designer had completed a $5 billion investment in the chipmaker, as a broader retreat in heavyweight

29 December 2025

Artificial Intelligence·Financial Analysis·Investments·Stock Market·Tech News

Silver whiplash slams PSLV as Sprott trust drops with bullion

NEW YORK, December 29, 2025, 15:05 ET — Regular session Units of Sprott Physical Silver Trust fell 7.6% to $24.05 in afternoon trading on Monday, tracking a sharp pullback in silver. The units swung between $25.32 and $23.41, with volume

29 December 2025

ETFs·Financial News·Market Analysis·Precious Metals

Allied Gold slides 7% as gold pulls back from record highs

NEW YORK, December 29, 2025, 15:07 ET — Regular session Allied Gold Corporation shares fell about 7.4% on Monday, tracking a broad pullback in precious metals. The stock was down $1.84 at $23.08 in afternoon trading after earlier touching $23.01.

29 December 2025

Commodities·Gold Prices·Investment News·Market Trends